Valeo Pharma Inc. (VPHIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0469
-0.0471 (-50.11%)
At close: Aug 29, 2024
Valeo Pharma Employees
Valeo Pharma had 110 employees as of October 31, 2023. The number of employees decreased by 5 or -4.35% compared to the previous year.
Employees
110
Change (1Y)
-5
Growth (1Y)
-4.35%
Revenue / Employee
$552,025
Profits / Employee
-$332,185
Market Cap
4.63M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 64 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| American Oncology Network | 1,914 |
Valeo Pharma News
- 2 years ago - VALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES AGREEMENT WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH COVID-19 AT HIGH RISK FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) - PRNewsWire
- 3 years ago - VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ENERZAIR® BREEZHALER® AND ATECTURA® BREEZHALER® IN ONTARIO, MANITOBA AND NEW BRUNSWICK - PRNewsWire
- 3 years ago - VALEO PHARMA'S HESPERCO™ NOW AVAILABLE AT LOBLAWS, HESPERIDIN COVID-19 CLINICAL TRIAL RESULTS SUBMITTED FOR PUBLICATION - PRNewsWire
- 3 years ago - Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec - GlobeNewsWire
- 3 years ago - Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec - GlobeNewsWire
- 3 years ago - Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta - PRNewsWire
- 3 years ago - /C O R R E C T I O N from Source -- Valeo Pharma inc./ - PRNewsWire
- 3 years ago - Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada - PRNewsWire